Swiss Re Ag · SIX:SREN
Swiss Re — Investor Presentation (2020)
19 slides from Swiss Re's investor presentation, 2020
Slide 1: COVID-19: Cancer Treatment Disruption
COVID-19: Cancer Treatment Disruption Dra. Erika Ruíz García Medical Oncologist
Slide 2: COVID-19 overview (Our World in Data)
https://ourworldindata.org/covid-overview
Slide 3: COVID-19 overview (Our World in Data)
https://ourworldindata.org/covid-overview
Slide 4: Patients with Cancer Appear More Vulnerable to SARS-CoV-2
Patients with Cancer Appear More Vulnerable to SARS-CoV-2: A Multicenter Study during the COVID-19 Outbreak Dai M, Cancer Discov (2020)
Slide 5: Best Practice: Cancer patient management during the COVID-19 pandemic
BEST PRACTICE Cancer patient management during cn sa the COVID-19 pandemic ESM0 e@ Discuss the benefits and risks of palliative therapy in the setting of the COVID-19 pandemic and local constraints, weighing in all relevant factors: disease prognosis, patient comorbidities, patient preferences, prob
Slide 6: Cancer Patient Prioritisation
Cancer Patient Prioritisation The tiered approach of ESMO in delivering a guidance for cancer patients during the COVID-19 pandemic is designed across three levels of priorities, namely: tier 1 (high priority intervention), 2 (medium priority) and 3 (low priority) — defined according to the criteria
Slide 7: NIH National Library of Medicine: cancer, covid-19
NIH) National Library of Medicine National Center for Biotechnology Information Publ{Mjed gov cancer, covid-19 Advanced Create alert Create RSS Save Email Send to MY NCBI FILTERS % RESULTS BY YEAR [-] Critical role of neutralizing antibody 1 transmission. ll Cite Kim YI, Kim SM, Park SJ, Kim EH, Yu
Slide 8: Patt D et al. JCO Clin Cancer Inform (2020)
Patt D et al. JCO Clin Cancer Inform. (2020)
Slide 9: Relative change in billing frequencies for cancer screening procedures
Relative change in billing fre- quencies for select cancer screening procedures (March-July 2019/2020) Patt D et al. JCO Clin Cancer Inform. (2020)
Slide 10: Relative change in billing for oncology products and chemotherapy administration
Relative change in billing frequencies for select physician-administered oncology products (at any site of services) and relative change in chemotherapy administration (by the site of service) (March-July 2019/2020) Patt D et al. JCO Clin Cancer Inform. (2020)
Slide 11: Relative change in billing for cancer-related biopsies and surgeries
Relative change in billing frequencies for cancer-related biopsies and surgeries (March July2019/2020) Patt D et al. JCO Clin Cancer Inform. (2020) In the USA, almost 10,000 excess deaths from breast and colorectal cancer are predicted over the next 10 years Sharpless, N. E. COVID-19 and cancer. Sci
Slide 12: July 2020: 1,868 cancer patients
• July 2020: 1,868 cancer patients, median age 60 (13-91y) https://www.cancerresearchuk.org/sites/default/files/pes-covid_2020.pdf
Slide 13: Cancer Research UK COVID-19 report
https://www.cancerresearchuk.org/sites/default/files/pes-covid_2020.pdf
Slide 14: Additional cancer deaths from delayed diagnosis
https://www.cancerresearchuk.org/sites/default/files/pes-covid_2020.pdf One study estimated that, within 5 years, >3,000 additional deaths from breast, lung, oesophageal and colorectal cancer will result from delayed diagnosis owing to COVID- 19-associated disruption to diagnostic services (UK) Mari
Slide 15: Research
Research • Globally, many clinical trials have been put on hold during • Cancer drug & Research the pandemic, and research development is a central aspect infrastructure has been of clinical care. repurposed for COVID-19 trials Hepatocarcinoma
Slide 16: Telemedicine, concerns
Telemedicine, concerns • Changes the degree of proximity between clinicians and patients, physically and emotionally. • Bad news, transition to palliative care • Ensuring cybersecurity • “Digital division” those who have access to, and are comfortable, and those who do not.
Slide 17: Take Home Message: Impact on Cancer Care
Take Home Message: Impact on Cancer Care • From hand hygiene stations and social distancing measures, through to the rapid expansion of telehealth and suspension or delay of clinical trial activities • COVID-19 has fundamentally reshaped oncology practice at every level. • Oncology community has see
Slide 18: Broom A, Clin Cancer Res (2020)
Broom A, Clin Cancer Res (2020)
Slide 19: Contact details
[email protected] @Betzabe100